25 XP   0   0   10

NexgenRX Inc.
Buy, Hold or Sell?

Let's analyse Nexgenrx together

PenkeI guess you are interested in NexgenRX Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of NexgenRX Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about NexgenRX Inc.

I send you an email if I find something interesting about NexgenRX Inc..

Quick analysis of Nexgenrx (30 sec.)










What can you expect buying and holding a share of Nexgenrx? (30 sec.)

How much money do you get?

How much money do you get?
C$0.01
When do you have the money?
1 year
How often do you get paid?
53.6%

What is your share worth?

Current worth
C$0.12
Expected worth in 1 year
C$0.11
How sure are you?
64.3%

+ What do you gain per year?

Total Gains per Share
C$0.00
Return On Investment
-1.3%

For what price can you sell your share?

Current Price per Share
C$0.24
Expected price per share
C$0.2052 - C$0.24
How sure are you?
50%

1. Valuation of Nexgenrx (5 min.)




Live pricePrice per Share (EOD)

C$0.24

Intrinsic Value Per Share

C$0.40 - C$0.48

Total Value Per Share

C$0.52 - C$0.60

2. Growth of Nexgenrx (5 min.)




Is Nexgenrx growing?

Current yearPrevious yearGrowGrow %
How rich?$6.2m$7m-$627.3k-9.7%

How much money is Nexgenrx making?

Current yearPrevious yearGrowGrow %
Making money-$57.1k$587.1k-$644.2k-1,128.2%
Net Profit Margin-2.3%23.6%--

How much money comes from the company's main activities?

3. Financial Health of Nexgenrx (5 min.)




4. Comparing to competitors in the Healthcare Plans industry (5 min.)




  Industry Rankings (Healthcare Plans)  


Richest
#16 / 18

Most Revenue
#18 / 18

Most Profit
#11 / 18

What can you expect buying and holding a share of Nexgenrx? (5 min.)

Welcome investor! Nexgenrx's management wants to use your money to grow the business. In return you get a share of Nexgenrx.

What can you expect buying and holding a share of Nexgenrx?

First you should know what it really means to hold a share of Nexgenrx. And how you can make/lose money.

Speculation

The Price per Share of Nexgenrx is C$0.24. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nexgenrx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nexgenrx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$0.12. Based on the TTM, the Book Value Change Per Share is C$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is C$0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nexgenrx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps0.00-0.6%0.00-0.3%0.013.3%0.001.3%0.000.7%
Usd Book Value Change Per Share0.00-0.4%0.00-0.8%0.012.6%0.001.5%0.001.3%
Usd Dividend Per Share0.000.1%0.000.6%0.001.0%0.000.4%0.000.3%
Usd Total Gains Per Share0.00-0.3%0.00-0.2%0.013.6%0.001.9%0.001.6%
Usd Price Per Share0.20-0.21-0.26-0.21-0.20-
Price to Earnings Ratio-36.42--170.30-41.57--28.41--15.73-
Price-to-Total Gains Ratio-324.77--1,498.11-55.25--256.25--188.06-
Price to Book Ratio2.24-2.30-2.61-4.67-8.09-
Price-to-Total Gains Ratio-324.77--1,498.11-55.25--256.25--188.06-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.176712
Number of shares5658
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (5658 shares)-3.1925.22
Gains per Year (5658 shares)-12.75100.87
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
131-43-23218091
261-87-3642160192
392-130-4963240293
4122-173-6284320394
5153-216-75105400495
6183-260-88126480596
7214-303-101147559697
8244-346-114168639798
9275-389-127189719899
10305-433-1402107991000

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%8.04.00.066.7%13.07.00.065.0%15.013.00.053.6%15.013.00.053.6%
Book Value Change Per Share1.03.00.025.0%7.05.00.058.3%13.07.00.065.0%17.011.00.060.7%17.011.00.060.7%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%15.00.05.075.0%15.00.013.053.6%15.00.013.053.6%
Total Gains per Share1.03.00.025.0%8.04.00.066.7%14.06.00.070.0%18.010.00.064.3%18.010.00.064.3%

Fundamentals of Nexgenrx

About NexgenRX Inc.

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

Fundamental data was last updated by Penke on 2024-03-20 08:01:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of NexgenRX Inc..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Nexgenrx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Nexgenrx to the Healthcare Plans industry mean.
  • A Net Profit Margin of -3.9% means that $-0.04 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of NexgenRX Inc.:

  • The MRQ is -3.9%. The company is making a loss. -1
  • The TTM is -2.3%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-3.9%TTM-2.3%-1.5%
TTM-2.3%YOY23.6%-25.9%
TTM-2.3%5Y10.1%-12.4%
5Y10.1%10Y4.6%+5.4%
Compared to industry (Healthcare Plans)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.9%1.1%-5.0%
TTM-2.3%2.2%-4.5%
YOY23.6%2.5%+21.1%
5Y10.1%3.2%+6.9%
10Y4.6%2.5%+2.1%
1.1.2. Return on Assets

Shows how efficient Nexgenrx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nexgenrx to the Healthcare Plans industry mean.
  • -0.4% Return on Assets means that Nexgenrx generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of NexgenRX Inc.:

  • The MRQ is -0.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.4%TTM-0.3%-0.1%
TTM-0.3%YOY2.7%-3.0%
TTM-0.3%5Y1.1%-1.4%
5Y1.1%10Y0.5%+0.6%
Compared to industry (Healthcare Plans)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.4%0.4%-0.8%
TTM-0.3%0.8%-1.1%
YOY2.7%1.2%+1.5%
5Y1.1%1.1%0.0%
10Y0.5%1.0%-0.5%
1.1.3. Return on Equity

Shows how efficient Nexgenrx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nexgenrx to the Healthcare Plans industry mean.
  • -1.5% Return on Equity means Nexgenrx generated $-0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of NexgenRX Inc.:

  • The MRQ is -1.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.5%TTM-0.9%-0.6%
TTM-0.9%YOY8.2%-9.1%
TTM-0.9%5Y5.1%-6.0%
5Y5.1%10Y1.7%+3.4%
Compared to industry (Healthcare Plans)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.5%2.2%-3.7%
TTM-0.9%2.7%-3.6%
YOY8.2%3.9%+4.3%
5Y5.1%3.4%+1.7%
10Y1.7%3.5%-1.8%

1.2. Operating Efficiency of NexgenRX Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Nexgenrx is operating .

  • Measures how much profit Nexgenrx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nexgenrx to the Healthcare Plans industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of NexgenRX Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY10.4%-10.4%
TTM-5Y9.9%-9.9%
5Y9.9%10Y4.4%+5.5%
Compared to industry (Healthcare Plans)
PeriodCompanyIndustry (mean)+/- 
MRQ--0.6%+0.6%
TTM-2.7%-2.7%
YOY10.4%4.4%+6.0%
5Y9.9%4.9%+5.0%
10Y4.4%4.7%-0.3%
1.2.2. Operating Ratio

Measures how efficient Nexgenrx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Healthcare Plans industry mean).
  • An Operation Ratio of 1.25 means that the operating costs are $1.25 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of NexgenRX Inc.:

  • The MRQ is 1.250. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.214. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.250TTM1.214+0.036
TTM1.214YOY1.096+0.118
TTM1.2145Y1.077+0.137
5Y1.07710Y1.137-0.060
Compared to industry (Healthcare Plans)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2501.096+0.154
TTM1.2141.116+0.098
YOY1.0961.093+0.003
5Y1.0771.152-0.075
10Y1.1371.162-0.025

1.3. Liquidity of NexgenRX Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Nexgenrx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Healthcare Plans industry mean).
  • A Current Ratio of 1.08 means the company has $1.08 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of NexgenRX Inc.:

  • The MRQ is 1.084. The company is just able to pay all its short-term debts.
  • The TTM is 1.091. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.084TTM1.091-0.006
TTM1.091YOY1.073+0.017
TTM1.0915Y0.990+0.101
5Y0.99010Y1.009-0.020
Compared to industry (Healthcare Plans)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0841.110-0.026
TTM1.0911.123-0.032
YOY1.0731.313-0.240
5Y0.9901.382-0.392
10Y1.0091.296-0.287
1.3.2. Quick Ratio

Measures if Nexgenrx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nexgenrx to the Healthcare Plans industry mean.
  • A Quick Ratio of 0.03 means the company can pay off $0.03 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of NexgenRX Inc.:

  • The MRQ is 0.028. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.031. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.028TTM0.031-0.003
TTM0.031YOY0.022+0.008
TTM0.0315Y0.026+0.005
5Y0.02610Y0.022+0.004
Compared to industry (Healthcare Plans)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0281.025-0.997
TTM0.0310.947-0.916
YOY0.0221.129-1.107
5Y0.0261.110-1.084
10Y0.0221.202-1.180

1.4. Solvency of NexgenRX Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Nexgenrx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nexgenrx to Healthcare Plans industry mean.
  • A Debt to Asset Ratio of 0.71 means that Nexgenrx assets are financed with 71.1% credit (debt) and the remaining percentage (100% - 71.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of NexgenRX Inc.:

  • The MRQ is 0.711. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.688. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.711TTM0.688+0.023
TTM0.688YOY0.682+0.006
TTM0.6885Y0.784-0.096
5Y0.78410Y0.810-0.026
Compared to industry (Healthcare Plans)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7110.693+0.018
TTM0.6880.694-0.006
YOY0.6820.678+0.004
5Y0.7840.661+0.123
10Y0.8100.655+0.155
1.4.2. Debt to Equity Ratio

Measures if Nexgenrx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nexgenrx to the Healthcare Plans industry mean.
  • A Debt to Equity ratio of 245.9% means that company has $2.46 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of NexgenRX Inc.:

  • The MRQ is 2.459. The company is just not able to pay all its debts with equity.
  • The TTM is 2.223. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.459TTM2.223+0.236
TTM2.223YOY2.151+0.072
TTM2.2235Y4.945-2.722
5Y4.94510Y5.946-1.001
Compared to industry (Healthcare Plans)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4592.264+0.195
TTM2.2232.283-0.060
YOY2.1512.124+0.027
5Y4.9451.975+2.970
10Y5.9461.993+3.953

2. Market Valuation of NexgenRX Inc.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Nexgenrx generates.

  • Above 15 is considered overpriced but always compare Nexgenrx to the Healthcare Plans industry mean.
  • A PE ratio of -36.42 means the investor is paying $-36.42 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of NexgenRX Inc.:

  • The EOD is -32.371. Based on the earnings, the company is expensive. -2
  • The MRQ is -36.417. Based on the earnings, the company is expensive. -2
  • The TTM is -170.300. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-32.371MRQ-36.417+4.046
MRQ-36.417TTM-170.300+133.883
TTM-170.300YOY41.573-211.874
TTM-170.3005Y-28.408-141.892
5Y-28.40810Y-15.730-12.678
Compared to industry (Healthcare Plans)
PeriodCompanyIndustry (mean)+/- 
EOD-32.37113.460-45.831
MRQ-36.41712.333-48.750
TTM-170.30010.983-181.283
YOY41.57310.036+31.537
5Y-28.40812.022-40.430
10Y-15.73018.758-34.488
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of NexgenRX Inc.:

  • The EOD is 6.457. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.264. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -4.835. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD6.457MRQ7.264-0.807
MRQ7.264TTM-4.835+12.099
TTM-4.835YOY3.079-7.914
TTM-4.8355Y-31.493+26.658
5Y-31.49310Y-30.101-1.392
Compared to industry (Healthcare Plans)
PeriodCompanyIndustry (mean)+/- 
EOD6.457-6.898+13.355
MRQ7.264-6.842+14.106
TTM-4.8350.617-5.452
YOY3.0794.008-0.929
5Y-31.4934.421-35.914
10Y-30.1013.622-33.723
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Nexgenrx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Healthcare Plans industry mean).
  • A PB ratio of 2.24 means the investor is paying $2.24 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of NexgenRX Inc.:

  • The EOD is 1.989. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.238. Based on the equity, the company is underpriced. +1
  • The TTM is 2.301. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.989MRQ2.238-0.249
MRQ2.238TTM2.301-0.063
TTM2.301YOY2.605-0.304
TTM2.3015Y4.674-2.373
5Y4.67410Y8.091-3.417
Compared to industry (Healthcare Plans)
PeriodCompanyIndustry (mean)+/- 
EOD1.9892.421-0.432
MRQ2.2382.408-0.170
TTM2.3012.064+0.237
YOY2.6052.654-0.049
5Y4.6742.825+1.849
10Y8.0913.060+5.031
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of NexgenRX Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.003+100%0.009-115%0.005-127%0.004-130%
Book Value Per Share--0.1210.124-3%0.136-11%0.083+45%0.065+87%
Current Ratio--1.0841.091-1%1.073+1%0.990+10%1.009+7%
Debt To Asset Ratio--0.7110.688+3%0.682+4%0.784-9%0.810-12%
Debt To Equity Ratio--2.4592.223+11%2.151+14%4.945-50%5.946-59%
Dividend Per Share--0.0000.002-74%0.003-85%0.001-63%0.001-48%
Eps---0.002-0.001-41%0.011-117%0.004-144%0.002-176%
Free Cash Flow Per Share--0.0090.002+450%0.009+3%0.004+130%0.002+282%
Free Cash Flow To Equity Per Share--0.0090.000+102%0.005+93%0.001+812%0.001+598%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.476--------
Intrinsic Value_10Y_min--0.402--------
Intrinsic Value_1Y_max--0.024--------
Intrinsic Value_1Y_min--0.023--------
Intrinsic Value_3Y_max--0.089--------
Intrinsic Value_3Y_min--0.085--------
Intrinsic Value_5Y_max--0.177--------
Intrinsic Value_5Y_min--0.163--------
Market Cap16927488.000-13%19043424.00020101392.000-5%25038576.000-24%19879939.500-4%19111951.0710%
Net Profit Margin---0.039-0.023-40%0.236-116%0.101-138%0.046-183%
Operating Margin----0%0.104-100%0.099-100%0.044-100%
Operating Ratio--1.2501.214+3%1.096+14%1.077+16%1.137+10%
Pb Ratio1.989-13%2.2382.301-3%2.605-14%4.674-52%8.091-72%
Pe Ratio-32.371+11%-36.417-170.300+368%41.573-188%-28.408-22%-15.730-57%
Price Per Share0.240-13%0.2700.285-5%0.355-24%0.282-4%0.2710%
Price To Free Cash Flow Ratio6.457-13%7.264-4.835+167%3.079+136%-31.493+534%-30.101+514%
Price To Total Gains Ratio-288.688+11%-324.774-1498.109+361%55.253-688%-256.253-21%-188.055-42%
Quick Ratio--0.0280.031-9%0.022+24%0.026+6%0.022+25%
Return On Assets---0.004-0.003-32%0.027-117%0.011-141%0.005-195%
Return On Equity---0.015-0.009-41%0.082-119%0.051-130%0.017-188%
Total Gains Per Share---0.001-0.001-8%0.012-107%0.006-114%0.005-116%
Usd Book Value--6265199.5256439468.114-3%7066840.812-11%4326743.068+45%3353575.410+87%
Usd Book Value Change Per Share---0.001-0.002+100%0.006-115%0.004-127%0.003-130%
Usd Book Value Per Share--0.0890.091-3%0.100-11%0.061+45%0.048+87%
Usd Dividend Per Share--0.0000.001-74%0.002-85%0.001-63%0.001-48%
Usd Eps---0.001-0.001-41%0.008-117%0.003-144%0.002-176%
Usd Free Cash Flow--482575.43887697.012+450%470017.657+3%209758.801+130%126429.863+282%
Usd Free Cash Flow Per Share--0.0070.001+450%0.007+3%0.003+130%0.002+282%
Usd Free Cash Flow To Equity Per Share--0.0070.000+102%0.004+93%0.001+812%0.001+598%
Usd Market Cap12463709.414-13%14021673.09114800654.930-5%18435903.509-24%14637599.454-4%14072129.5740%
Usd Price Per Share0.177-13%0.1990.210-5%0.261-24%0.207-4%0.1990%
Usd Profit---96257.235-57102.090-41%587107.213-116%226152.189-143%133008.966-172%
Usd Revenue--2496185.1162513025.218-1%2396029.541+4%2141995.548+17%1835664.797+36%
Usd Total Gains Per Share---0.001-0.001-8%0.009-107%0.004-114%0.004-116%
 EOD+4 -4MRQTTM+10 -24YOY+11 -245Y+16 -1910Y+16 -19

3.2. Fundamental Score

Let's check the fundamental score of NexgenRX Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-32.371
Price to Book Ratio (EOD)Between0-11.989
Net Profit Margin (MRQ)Greater than0-0.039
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.028
Current Ratio (MRQ)Greater than11.084
Debt to Asset Ratio (MRQ)Less than10.711
Debt to Equity Ratio (MRQ)Less than12.459
Return on Equity (MRQ)Greater than0.15-0.015
Return on Assets (MRQ)Greater than0.05-0.004
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of NexgenRX Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.111
Ma 20Greater thanMa 500.230
Ma 50Greater thanMa 1000.233
Ma 100Greater thanMa 2000.232
OpenGreater thanClose0.240
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CAD. All numbers in thousands.

Summary
Total Assets29,437
Total Liabilities20,928
Total Stockholder Equity8,509
 As reported
Total Liabilities 20,928
Total Stockholder Equity+ 8,509
Total Assets = 29,437

Assets

Total Assets29,437
Total Current Assets22,302
Long-term Assets7,134
Total Current Assets
Cash And Cash Equivalents 1,937
Net Receivables 571
Total Current Assets  (as reported)22,302
Total Current Assets  (calculated)2,509
+/- 19,794
Long-term Assets
Property Plant Equipment 765
Goodwill 1,241
Intangible Assets 3,416
Long-term Assets  (as reported)7,134
Long-term Assets  (calculated)5,421
+/- 1,713

Liabilities & Shareholders' Equity

Total Current Liabilities20,568
Long-term Liabilities360
Total Stockholder Equity8,509
Total Current Liabilities
Other Current Liabilities 19,581
Total Current Liabilities  (as reported)20,568
Total Current Liabilities  (calculated)19,581
+/- 987
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt399
Long-term Liabilities  (as reported)360
Long-term Liabilities  (calculated)399
+/- 39
Total Stockholder Equity
Total Stockholder Equity (as reported)8,509
Total Stockholder Equity (calculated)0
+/- 8,509
Other
Capital Stock5,474
Common Stock Shares Outstanding 70,531
Net Invested Capital 6,859
Net Working Capital 1,734
Property Plant and Equipment Gross 1,581



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
8,185
8,563
8,922
9,052
9,668
9,568
8,731
19,894
18,023
19,525
18,491
18,706
21,194
23,226
26,432
27,522
25,245
27,776
27,506
27,611
29,436
31,429
30,710
29,397
25,747
28,600
28,848
29,437
29,43728,84828,60025,74729,39730,71031,42929,43627,61127,50627,77625,24527,52226,43223,22621,19418,70618,49119,52518,02319,8948,7319,5689,6689,0528,9228,5638,185
   > Total Current Assets 
7,484
7,878
8,071
8,073
8,625
8,468
7,611
15,022
12,354
12,948
11,832
11,975
14,461
16,656
19,829
20,847
18,374
20,986
20,595
20,843
20,831
23,085
22,246
21,043
18,004
21,159
21,544
22,302
22,30221,54421,15918,00421,04322,24623,08520,83120,84320,59520,98618,37420,84719,82916,65614,46111,97511,83212,94812,35415,0227,6118,4688,6258,0738,0717,8787,484
       Cash And Cash Equivalents 
681
524
344
318
2,027
1,317
1,155
707
834
675
616
458
527
710
825
839
802
413
809
602
2,317
1,393
1,792
1,994
1,767
1,264
1,270
1,937
1,9371,2701,2641,7671,9941,7921,3932,3176028094138028398257105274586166758347071,1551,3172,027318344524681
       Net Receivables 
61
94
44
55
49
209
49
410
592
439
603
542
313
373
239
497
355
509
361
356
479
496
441
410
410
774
586
571
571586774410410441496479356361509355497239373313542603439592410492094955449461
       Other Current Assets 
6,663
7,200
7,580
7,631
6,477
6,876
6,316
13,847
10,870
11,742
10,492
10,884
13,494
15,436
18,622
19,398
17,043
19,941
19,203
19,526
17,874
20,978
19,772
18,478
0
0
0
0
000018,47819,77220,97817,87419,52619,20319,94117,04319,39818,62215,43613,49410,88410,49211,74210,87013,8476,3166,8766,4777,6317,5807,2006,663
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
6,577
6,659
6,730
6,732
6,570
6,603
6,675
6,871
6,790
6,911
6,768
8,605
8,343
8,464
8,354
7,743
7,441
7,305
7,134
7,1347,3057,4417,7438,3548,4648,3438,6056,7686,9116,7906,8716,6756,6036,5706,7326,7306,6596,577000000000
       Property Plant Equipment 
124
130
133
123
120
124
115
141
129
1,024
961
904
856
833
779
708
692
712
632
554
504
418
802
931
835
797
757
765
7657577978359318024185045546327126927087798338569049611,024129141115124120123133130124
       Goodwill 
0
0
0
0
0
0
0
548
1,241
1,241
1,241
1,241
1,241
1,241
1,241
1,241
1,241
1,241
1,241
1,241
1,241
1,241
1,241
1,241
1,241
1,241
1,241
1,241
1,2411,2411,2411,2411,2411,2411,2411,2411,2411,2411,2411,2411,2411,2411,2411,2411,2411,2411,2411,2415480000000
       Intangible Assets 
358
336
499
636
694
747
779
3,957
4,249
4,262
4,407
4,526
4,588
4,448
4,535
4,681
4,893
4,792
4,993
4,928
5,116
4,917
4,631
4,369
4,097
3,812
3,691
3,416
3,4163,6913,8124,0974,3694,6314,9175,1164,9284,9934,7924,8934,6814,5354,4484,5884,5264,4074,2624,2493,957779747694636499336358
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
6,577
6,659
6,730
6,732
6,570
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000006,5706,7326,7306,6596,577000000000
> Total Liabilities 
7,427
7,762
8,170
8,450
7,706
7,726
7,189
18,150
16,066
17,492
16,445
16,832
19,353
21,082
23,782
22,740
19,723
21,714
21,087
20,786
19,723
21,701
21,001
20,156
16,896
19,578
20,248
20,928
20,92820,24819,57816,89620,15621,00121,70119,72320,78621,08721,71419,72322,74023,78221,08219,35316,83216,44517,49216,06618,1507,1897,7267,7068,4508,1707,7627,427
   > Total Current Liabilities 
7,167
7,508
7,918
8,202
7,253
7,298
6,784
16,611
13,829
14,399
13,382
12,559
17,821
19,770
22,574
21,648
18,997
21,011
20,407
20,128
19,551
21,583
20,473
19,628
16,506
19,188
19,857
20,568
20,56819,85719,18816,50619,62820,47321,58319,55120,12820,40721,01118,99721,64822,57419,77017,82112,55913,38214,39913,82916,6116,7847,2987,2538,2027,9187,5087,167
       Short-term Debt 
211
193
175
157
126
108
90
1,844
1,836
1,782
1,874
507
2,893
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000002,8935071,8741,7821,8361,84490108126157175193211
       Short Long Term Debt 
211
193
175
157
126
108
90
1,844
1,836
1,782
1,874
507
2,893
2,953
2,712
1,035
773
0
0
0
0
0
0
0
0
0
0
0
000000000007731,0352,7122,9532,8935071,8741,7821,8361,84490108126157175193211
       Accounts payable 
425
245
294
546
631
295
359
901
1,093
696
894
1,118
1,160
1,111
998
1,036
878
831
1,030
492
1,414
358
591
700
922
0
0
0
0009227005913581,4144921,0308318781,0369981,1111,1601,1188946961,093901359295631546294245425
       Other Current Liabilities 
6,681
7,220
7,598
7,649
6,496
6,895
6,335
13,866
10,899
11,739
10,489
10,865
13,471
15,420
18,613
19,398
17,076
19,975
19,233
19,559
17,907
21,065
19,772
18,895
15,541
18,819
19,332
19,581
19,58119,33218,81915,54118,89519,77221,06517,90719,55919,23319,97517,07619,39818,61315,42013,47110,86510,48911,73910,89913,8666,3356,8956,4967,6497,5987,2206,681
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
3,093
3,063
4,273
1,532
1,312
1,208
1,092
726
703
680
657
172
172
528
528
390
390
390
360
3603903903905285281721726576807037261,0921,2081,3121,5324,2733,0633,093000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
1,049
993
936
878
824
790
717
673
609
547
480
402
332
637
560
432
422
410
399
3994104224325606373324024805476096737177908248789369931,049000000000
       Deferred Long Term Liability 
0
0
0
0
9
8
7
6
6
5
4
14
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000003331445667890000
> Total Stockholder Equity
758
801
752
602
1,962
1,841
1,543
1,744
1,957
2,033
2,046
1,873
1,841
2,144
2,650
4,782
5,522
6,062
6,419
6,825
9,713
9,728
9,709
9,242
8,851
9,022
8,601
8,509
8,5098,6019,0228,8519,2429,7099,7289,7136,8256,4196,0625,5224,7822,6502,1441,8411,8732,0462,0331,9571,7441,5431,8411,962602752801758
   Common Stock
16,815
16,839
16,899
16,899
18,611
18,611
18,611
18,761
19,186
19,186
19,186
19,186
19,186
19,186
19,186
19,186
19,186
19,286
19,286
19,286
19,286
19,286
19,286
19,286
19,286
0
0
0
00019,28619,28619,28619,28619,28619,28619,28619,28619,18619,18619,18619,18619,18619,18619,18619,18619,18618,76118,61118,61118,61116,89916,89916,83916,815
   Retained Earnings -1,336-1,172-16,271-16,433-16,034-15,552-15,532-15,525-18,370-18,766-19,114-19,444-20,240-20,750-21,233-21,513-21,469-21,250-21,215-21,243-21,431-21,029-20,705-20,556-20,174-20,022-19,933-19,955
   Capital Surplus 0000000000000000000000000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
425
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000004250000000



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue13,652
Cost of Revenue-2,900
Gross Profit10,75310,753
 
Operating Income (+$)
Gross Profit10,753
Operating Expense-13,673
Operating Income-21-2,921
 
Operating Expense (+$)
Research Development-
Selling General Administrative1,394
Selling And Marketing Expenses-
Operating Expense13,6731,394
 
Net Interest Income (+$)
Interest Income-
Interest Expense-27
Other Finance Cost-132
Net Interest Income-159
 
Pretax Income (+$)
Operating Income-21
Net Interest Income-159
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-152-21
EBIT - interestExpense = -27
-421
-395
Interest Expense27
Earnings Before Interest and Taxes (EBIT)--125
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-152
Tax Provision-158
Net Income From Continuing Ops-310-310
Net Income-421
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-159
 

Technical Analysis of Nexgenrx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nexgenrx. The general trend of Nexgenrx is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nexgenrx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of NexgenRX Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.24 < 0.24 < 0.24.

The bearish price targets are: 0.21 > 0.2052 > 0.2052.

Tweet this
NexgenRX Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of NexgenRX Inc.. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

NexgenRX Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of NexgenRX Inc.. The current macd is 0.0022507.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nexgenrx price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Nexgenrx. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Nexgenrx price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
NexgenRX Inc. Daily Moving Average Convergence/Divergence (MACD) ChartNexgenRX Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of NexgenRX Inc.. The current adx is 25.60.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Nexgenrx shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
NexgenRX Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of NexgenRX Inc.. The current sar is 0.18465791.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
NexgenRX Inc. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of NexgenRX Inc.. The current rsi is 56.11. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
NexgenRX Inc. Daily Relative Strength Index (RSI) ChartNexgenRX Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of NexgenRX Inc.. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Nexgenrx price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
NexgenRX Inc. Daily Stochastic Oscillator ChartNexgenRX Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of NexgenRX Inc.. The current cci is 60.61.

NexgenRX Inc. Daily Commodity Channel Index (CCI) ChartNexgenRX Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of NexgenRX Inc.. The current cmo is 19.44.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
NexgenRX Inc. Daily Chande Momentum Oscillator (CMO) ChartNexgenRX Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of NexgenRX Inc.. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
NexgenRX Inc. Daily Williams %R ChartNexgenRX Inc. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of NexgenRX Inc..

NexgenRX Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of NexgenRX Inc.. The current atr is 0.00639178.

NexgenRX Inc. Daily Average True Range (ATR) ChartNexgenRX Inc. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of NexgenRX Inc.. The current obv is -567,500.

NexgenRX Inc. Daily On-Balance Volume (OBV) ChartNexgenRX Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of NexgenRX Inc.. The current mfi is 62.70.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
NexgenRX Inc. Daily Money Flow Index (MFI) ChartNexgenRX Inc. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for NexgenRX Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-22MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-27MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-05MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

NexgenRX Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of NexgenRX Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.111
Ma 20Greater thanMa 500.230
Ma 50Greater thanMa 1000.233
Ma 100Greater thanMa 2000.232
OpenGreater thanClose0.240
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Nexgenrx with someone you think should read this too:
  • Are you bullish or bearish on Nexgenrx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nexgenrx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about NexgenRX Inc.

I send you an email if I find something interesting about NexgenRX Inc..


Comments

How you think about this?

Leave a comment

Stay informed about NexgenRX Inc..

Receive notifications about NexgenRX Inc. in your mailbox!